Vanderbilt Eye Institute

Team tracking new options to treat glaucoma

Three years ago, a team of researchers led by David Calkins, Ph.D., vice chair and director of Research at the Vanderbilt Eye Institute, showed that the first sign of injury in glaucoma, the leading cause of blindness in the United States, occurs in the brain.

Glaucoma patients focus of Sousan’s sharing nature

Suzanne Sousan is not afraid of much.

Glasses bring girl’s world back in focus

Once upon a time, teenage girls were not clamoring to sport a pair of thick, black, oversized eyeglasses.

Grant to support blindess research

Research to Prevent Blindness (RPB) recently awarded a $110,000 grant to Vanderbilt’s Department of Ophthalmology and Visual Sciences in support of research into the causes, treatment and prevention of blinding diseases.

‘Bionic eye’ new option for retinitis pigmentosa patients

Vanderbilt University Medical Center has been chosen as one of 12 sites in the United States to offer the first FDA-approved bionic eye for the treatment of retinitis pigmentosa (RP).

Vanderbilt ophthalmologist stresses summer eye safety

1 7 8 9 10 11